Jiang, G., Yang, X., Xie, J., Yu, X., Chen, S., Tan, Q., Zeng, Y., Zheng, R., Li, L., Zhang, W., Yin, X., Liu, K., Jia, J. (2025). Osimertinib plus anlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer with concurrent gene alterations: A single-arm, prospective, multicenter phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8627